Targeting LFA-1 and CD154 suppresses the in vivo activation and development of cytolytic (CD4-idependent) CD8+ T cells

Journal of Immunology

Volumn 175, Issue 12, 2005, Pages 7855-7866

  Lunsford, Keri E ^a   Koester, Mitchel A ^a   Eiring, Anna M ^a   Horne, Phillip H ^a   Gao, Donghong ^a   Bumgardner, Ginny L ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD154 ANTIBODY; CD40 LIGAND; CD8 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1 ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANTIGEN PRESENTING CELL; CELL INFILTRATION; CELL TRANSPLANTATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IMMUNOTHERAPY; IN VIVO STUDY; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION;

EID: 29144506023     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.12.7855     Document Type: Conference Paper

References (66)

1. Bumgardner, G. L., D. Gao, J. Li, J. Baskin, M. Heininger, and C. G. Orosz. 2000. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4 KO, and CD8 KO mice. Transplantation 70: 1771-1780.
2. + T-cell responses in acute rejection. Transplantation 68: 555-562.
3. Wang, Y., D. Gao, K. E. Lunsford, W. L. Frankel, and G. L. Bumgardner. 2003. Targeting LFA-1 synergizes with CD40/CD40L blockade for suppression of both CD4-dependent and CD8-dependent rejection. Am. J. Transplant 3: 1251-1258.
4. Lunsford, K. E., D. Gao, A. M. Erring, Y. Wang, W. L. Frankel, and G. L. Bumgardner. 2004. Evidence for tissue directed immune responses: analysis of CD4-dependent and CD8-dependent alloimmunity. Transplantation 78: 1125-1133.
5. + T cells in allograft acceptance induced by DST and CD40/CD154 costimulatory blockade. Am. J. Transplant. 4: 1061-1070.
6. + cells that independently initiate rejection of allogeneic hepatocytes in mice. Hepatology 32: 1018-1028.
7. + T cells can trigger allograft rejection. J. Immunol. 165: 1111-1118.
8. + cells and CD40-CD40 ligand interactions. J. Immunol. 6: 3248-3255
9. + T cells play a critical role in costimulation blockade-resistant allograft rejection. J. Clin. Invest. 104; 1715.
10. + T cells. J. Immunol 163: 2358-2362.
11. Guo, Z., L. Meng, O. Kim, J. Wang, J. Hart, G. He, M. L. Alegre, J. R. Thistlethwaite, Jr., T. C. Pearson, C. P. Larsen, and K. A. Newell. 2001. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation 71: 1351-1354.
12. + T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation 61: 131.
13. Han, W. R., Y. Zhan, L. J. Murray-Segal, J. L. Brady, A. M. Lew, and P. L. Mottram. 2000. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice. Transplantation 70: 168-174.
14. L induction, and is prevented by an inhibitor of phosphoinositide 3-kinase activity. J. Biol. Chem. 279: 910-919.
15. + T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection: Transplantation 77: 1815-1820.
16. Bumgardner, G. L., D. Gao, J. Li, A. Bickerstaff, and C. Orosz. 2002. MHC-identical heart and hepatocyte allografts evoke opposite immune responses within the same host. Transplantation 74: 855-864.
17. + T cells and prolonged graft survival in a CTLA4-dependent manner. The J. Immunol. 164: 512-521.
18. Abraham, C., J. Griffith, and J. Miller. 1999. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand. J. Immunol. 162: 4399-4405.
19. Ni, H. T., M. J. Deeths, W. Li, D. L. Mueller, and M. F. Mescher. 1999. Signaling pathways activated by LFA-1 dependent costimulation. J. Immunol. 162: 5183-5189.
20. + T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling. J. Immunol. 163: 4826-4832.
21. + T cells. Eur. J. Immunol. 29: 809-814.
22. + T cells are poorly costimulated by ICAM-1. Eur. J. Immunol. 29: 45-53.
23. Nicolls, M. R., M. Coulombe, J. Beilke, H. C. Gelhaus, and R. G. Gill. 2002. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways. J. Immunol. 169: 4831-4839.
24. + T cells, interferon-γ, and CTLA4. J. Clin. Invest. 101: 2446-2455.
25. Cobbold, S. P., G. Martin, and H. Waldmann. 1990. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed-recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur. J. Immunol. 20: 2747-2755.
26. Davies, J. D., S. P. Cobbold, and H. Waldmann. 1997. Strain variation in susceptibility to monoclonal antibody-induced transplantation tolerance. Transplantation 63: 1570-1573.
27. + T cells. Proc. Natl. Acad. Sci. USA 101: 10122-10126.
28. + T cell function but not expansion. Nat. Immunol. 3: 1208-1213.
29. Rothstein, D. M., M. F. A. Livak, K. Kishimoto, C. Ariyan, H.-Y. Qian, S. Fecteau, M. Sho, S. Deng, X. X. Zheng, M. H. Sayegh, and G. P. Basadonna. 2001. Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models. J. Immunol. 166: 322-329.
30. Zhang, Z.-X., L. Yang, K. J. Young, B. DuTemple, and L. Zhang. 2000. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat. Med. 6: 782-789.
31. Demirci, G., F. Amanullah, R. Kewalaramani, H. Yagita, T. B. Strom, M. H. Sayegh, and X. C. Li. 2004. Critical role of OX40 in CD28 and CD154-independent rejection. J. Immunol. 172: 1691-1698.
32. Guo, Z., J. Wang, Y. Dong, A. B. Adams, N. Shirasugi, O. Kim, J. Hart, M. Newton-West, T. C. Pearson, C. P. Larsen, and K. A. Newell. 2003. Long-term survival of intestinal allografts induced by costimulation blockade, busulfan and donor bone marrow infusion. Am. J. Transplant. 3: 1091-1098.
33. Bumgardner, G. L., J. Li, M. Heininger, R. M. Ferguson, and C. G. Orosz. 1998. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplantation 65: 47-52.
34. Bumgardner, G. L., M. Heininger, J. Li, D. Xia, J. Parker-Thornburg, R. M. Ferguson, and C. G. Orosz. 1998. A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation 65: 53-61.
35. Seglen, P. O. 1973. Preparation of rat liver parenchymal cells: enzymatic requirements for tissue dispersion. Exp. Cell Res. 82: 391-398.
36. Seglen, P. O. 1976. Preparation of isolated rat liver cells. Methods Cell Biol. 13: 30-83.
37. Bumgardner, G. L., and C. G. Orosz. 2000. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells. Immunol. Rev. 174: 260-279.
38. Crispe, I. N. 1997. Isolation of mouse intrahepatic lymphocytes. In Current Protocols in Immunology, New York, pp. 3.21.1-3.21.8.
39. + T lymphocyte responses. Nat. Immunol. 4: 361-365.
40. Oehen, S., and K. Brduscha-Riem. 1998. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161: 5338-5346.
41. Foy, T. M., D. M. Shepherd, F. H. Durie, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178: 1567-1575.
42. Andrew, D. P., J. P. Spellberg, H. Takimoto, R. Schmits, T. W. Mak, and M. M. Zukowski. 1998. Transendothelial migration and trafficking of leukocytes in LFA-1-deficient mice. Eur. J. Immunol. 28: 1959-1969.
43. + CTL. J. Immunol. 159: 3748-3756.
44. + T cells. J. Exp. Med. 196: 877-886.
45. Ashida, K., T. Terada, Y. Kitamura, and N. Kaibara. 1998. Expression of E-cadherin, α-catenin, β-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. Hepatology 27: 974-982.
46. + T cells by altered expression of cell surface O-glycans. J. Exp. Med. 191: 1241-1246.
47. Nathan, M. J., D. Yin, E. J. Eichwald, and D. K. Bishop. 2002. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells. Am. J. Transplant. 2: 323-332.
48. Rossini, A. A., D. C. Parker, N. E. Phillips, F. H. Durie, R. J. Noelle, J. P. Mordes, and D. L. Greiner. 1996. Induction of immunological tolerance to islet allografts. Cell Transplant. 5: 49-52.
49. Phillips, N. E., T. G. Markees, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 2003. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance. J. Immunol. 170: 3015-3023.
50. + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J. Immunol. 169: 5401-5404.
51. + T cells responding to renal allografts. J. Immunol. 172: 214-221.
52. + T cells in human livers; its association with extrathymic T cells. J. Hepatol. 39: 918-924.
53. 7 recognizes a ligand on mucosal epithelial cell lines. Eur. J. Immunol 23: 1630-1635.
54. + CTL response. J. Exp. Med. 183: 2129-2142.
55. Toes, R. E. M., S. P. Schoenberger, E. I. H. van der Voort, R. Offringa, and C. J. M. Melief. 1998. CD40-CD40 ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity. Sem. Immunol. 10: 443-448.
56. + T cells by skin grafts via direct antigen presentation. J. Immunol 169: 1270-1276.
57. Ziegler, S. F., F. Ramsdell, and M. R. Alderson. 1994. The activation antigen CD69. Stem. Cells 12: 456-465.
58. Nishimura, T., H. Kitamura, K. Iwakabe, T. Yahata, A. Ohta, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, et al. 2000. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12: 987-994.
59. + high regulatory cells in human peripheral blood. J. Immunol. 167: 1245-1253.
60. + regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J. Immunol. 172: 6539-6544.
61. + regulatory thymocytes. Blood 102: 4107-4114.
62. Corbascio, M., H. Mahanty, C. Osterholm, Z. Qi, T. C. Pearson, C. P. Larsen, C. E. preise, and H. Ekberg. 2002. Anti-lymphocyte function-associated amigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice. Transplantation 74: 35-41.
63. Xu, Q., J. S. Cao, and X. M. Zhang. 2002. Liver-infiltrating T lymphocytes cause hepatocyte damage by releasing humoral factors via LFA-1/ICAM-1 interaction in immunological liver injury. Inflamm. Res. 51: 44-50.
64. Ruth, A. J., A. R. Kitching, M. Li, T. J. Semple, J. R. Timoshanko, P. G. Tipping, and S. R. Holdsworth. 2004. An IL-12-independent role for CD40-CD154 in mediating effector responses: studies in cell-mediated glomerulonephritis and dermal delayed-type hypersensitivity. J. Immunol. 173: 136-144.
65. Rocca, E. L., C. Gobbi, D. Ciurlino, V. D. Carlo, G. Pozza, and A. Secchi. 1998. Improvement of glucose/insulin metabolism reduces hypertension of insulin-dependent diabetes melitis recipients of kidney-pancreas transplantation. Transplantation 64: 390-393.
66. Li, L., S. Sad, D. Kagi, and T. R. Mosmann. 1997. CD8 Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J. Immunol. 158: 4152-4161.